Hepion Pharmaceuticals

Funding and NIH signals

• SEC Form D raise Raised $3.06M (Form D filed Aug 5, 2026); +1 other Form D filing in the last 12 months. SEC Form D 0001493152-26-036216 (Aug 5, 2026)
  Evidence (2 events)

  • Aug 5, 2026 · SEC Form D 0001493152-26-036216
    Name of Issuer: Hepion Pharmaceuticals, Inc.; CIK: 1583771; Address: Red Bank, NJ; Submission type: D; Filing date: 2026-08-05; Industry Group: Biotechnology; Date of First Sale: 2026-07-31; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 3055000; Total Amount Sold: 3055000; Federal exemptions: 06b
  • Apr 22, 2026 · SEC Form D 0001493152-26-018593
    Name of Issuer: Hepion Pharmaceuticals, Inc.; CIK: 1583771; Address: Red Bank, NJ; Submission type: D; Filing date: 2026-04-22; Industry Group: Biotechnology; Date of First Sale: 2026-04-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 700000; Total Amount Sold: 700000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals